Vesco KK, Whitlock EP, Eder M, Burda BU, Senger CA, Lutz K. Ann Intern Med 2011;155:698-705
Winter 2012 Articles
Risk Factors and Other Epidemiologic Considerations for Cervical Cancer Screening: A Narrative Review for the U.S. Preventive Services Task Force
Kimberly K. Vesco, MD, MPH; Evelyn P. Whitlock, MD, MPH; Michelle Eder, PhD; Brittany U. Burda, MPH; Caitlyn A. Senger, MPH; and Kevin Lutz, MFA
Cervical Cancer Screening With Both Human Papillomavirus and Papanicolaou Testing vs Papanicolaou Testing Alone
Mona Saraiya, MD, MPH; Zahava Berkowitz, MSc, MSPH; K. Robin Yabroff, PhD, MBA; Louise Wideroff, PhD; Sarah Kobrin, PhD, MPH; Vicki Benard, PhD
Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States
Katherine B. Roland, MPH; Ashwini Soman, MBBS, MPH; Vicki B. Benard, PhD; Mona Saraiya, MD, MPH
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
Philip E Castle, Mark H Stoler, Thomas C Wright Jr, Abha Sharma, Teresa L Wright, Catherine M Behrens
The ATHENA human papillomavirus study: design, methods, and baseline results
Thomas C. Wright Jr, MD; Mark H. Stoler, MD; Catherine M. Behrens, MD, PhD; Raymond Apple, PhD; Toniann Derion, PhD; Teresa L. Wright, MD
High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology
Mark H. Stoler, MD, Thomas C. Wright, Jr, MD, Abha Sharma, PhD, Raymond Apple, PhD, Karen Gutekunst, PhD, Teresa L. Wright, MD, and the ATHENA (Addressing THE Need for Advanced HPV Diagnostics) HPV Study Group
Summer 2011 Literature Update/Commentary
HPV Testing in Combination with Liquid-Based Cytology in Primary Cervical Screening (ARTISTIC): A Randomised Controlled Trial
Kitchener H., et al. The Lancet 2009;107:672-682
A Comparison of HPV DNA Testing and Liquid Based Cytology Over Three Rounds of Primary Cervical Screening: Extended Follow Up in the ARTISTIC Trial
Kitchener H., et al. European Journal of Cancer. 2011; 47: 864-871
Summer 2011 Articles
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial
Henry C Kitchener, Maribel Almonte, Claire Thomson, Paula Wheeler, Alexandra Sargent, Boyka Stoykova, Clare Gilham, Helene Baysson, Christopher Roberts, Robin Dowie, Mina Desai, Jean Mather, Andrew Bailey, Andrew Turner, Sue Moss, Julian Peto
A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial
Henry C. Kitchener, Clare Gilham, Alexandra Sargent, Andrew Bailey, Rebecca Albrow, Christopher Roberts, Mina Desai, Jean Mather, Andrew Turner, Sue Moss, Julian Peto
FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP)
Morbidity and Mortality Weekly Report Weekly / Vol. 59 / No. 20 - May 28, 2010
Erratum - Morbidity and Mortality Weekly Report Weekly / Vol. 59 / No. 36 - September 17, 2010
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
Hormuzd A Katki, Walter K Kinney, Barbara Fetterman, Thomas Lorey, Nancy E Poitras, Li Cheung, Franklin Demuth, Mark Schiffman, Sholom Wacholder, Philip E Castle
Human Papillomavirus (HPV) Genotypes in Women with Cervical Precancer and Cancer at Kaiser Permanente Northern California
Philip E. Castle, Ruth Shaber, Brandon J. LaMere, et al.
Fall 2009 Literature Update/Commentary
Educate the Educators Literature Update
Michael A. Gold, MD Kenneth L. Noller, MD Jeffrey Waldman, MD Thomas C. Wright, MD
Fall 2009 HPV DNA Lecture Slides:Prevalence of hrHPV
Fall 2009 Articles
Five-Year Experience of Human Papillomavirus DNA and Papanicolaou Test Cotesting
Philip E. Castle, PhD MPH, Barbara Fetterman, SCT (ASCP), Nancy Poitras, PMP, Thomas Lorey, MD, Ruth Shaber, MD, and Walter Kinney, MD
Human Papillomavirus Infection and Cervical Cytology in Women Screened for Cervical Cancer in the United States, 2003–2005
S. Deblina Datta, MD; Laura A. Koutsky, PhD; Sylvie Ratelle, MD†; Elizabeth R. Unger, MD, PhD; Judith Shlay, MD, MSPH; Tracie McClain, MD; Beth Weaver, MD; Peter Kerndt, MD; Jonathan Zenilman, MD; Michael Hagensee, MD, PhD; Cristen J. Suhr, MPH, CHES; and Hillard Weinstock, MD, MPH
Adjunctive Human Papillomavirus DNA Testing Is a Useful Option in Some Clinical Settings for Disease Risk Assessment and Triage of Females With ASC-H Papanicolaou Test Results
Sudeshna Bandyopadhyay, MD; R. Marshall Austin, MD, PhD; David Dabbs, MD; Chengquan Zhao, MD
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
J Paavonen, P Naud, J Salmerón, C M Wheeler, S-N Chow, D Apter, H Kitchener, X Castellsague, J C Teixeira, S R Skinner, J Hedrick, U Jaisamrarn, G Limson, S Garland, A Szarewski, B Romanowski, F Y Aoki, T F Schwarz, W A J Poppe, F X Bosch, D Jenkins, K Hardt, T Zahaf, D Descamps, F Struyf, M Lehtinen, G Dubin, for the HPV PATRICIA Study Group
Spring 2009 Literature Update/Commentary
Educate the Educators Literature Update
Michael A. Gold, MD Kenneth L. Noller, MD Jeffrey Waldman, MD Thomas C. Wright, MD
Spring 2009 HPV DNA Lecture Slides
Spring 2009 Articles
Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening
Pontus Naucler, Walter Ryd, Sven Törnberg, Anders Strand, Göran Wadell, Kristina Elfgren, Thomas Rådberg, Björn Strander, Ola Forslund, Bengt-Göran Hansson, Björn Hagmar, Bo Johansson, Eva Rylander, Joakim Dillner
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
Joakim Dillner, professor, Matejka Rebolj, researcher, Philippe Birembaut, professor and head of department, Karl-Ulrich Petry, professor, Anne Szarewski, clinical consultant and honorary senior lecturer, Christian Munk, researcher, Silvia de Sanjose, researcher, Pontus Naucler, research fellow, Belen Lloveras, researcher, Susanne Kjaer, professor, Jack Cuzick, professor and head of department, Marjolein van Ballegooijen, professor, Christine Clavel, professor, Thomas Iftner, professor and head of section
Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2
Philip E. Castle, PhD, MPH, Mark Schiffman, MD, MPH, Cosette M. Wheeler, PhD, and Diane Solomon, MD
Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis
Hugo De Vuyst1, Gary M. Clifford1, Maria Claudia Nascimento1, Margaret M. Madeleine2 and Silvia Franceschi1*
(1International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon cedex 08, France 2Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA)
|